wehewehe
ʻO Vorolazan Intermediate 5 kahi mea nui i ka synthesis o Vorolazan, kahi papa o nā pūhui lāʻau ikaika i ʻike ʻia no kā lākou hopena therapeutic.He kuleana koʻikoʻi kēia waena i ka hana ʻana o Vorolazan, i hoʻohana ʻia i ka hoʻomohala ʻana i nā lāʻau lapaʻau like ʻole.
ʻO ka molecular structure o Vorolazan Intermediate 5 he hui 2-fluorophenyl i hoʻopili ʻia i ka moiety pyrrole-3-carboxaldehyde, hāʻawi iā ia i nā waiwai kemika kūʻokoʻa e waiwai nui ai i ka noiʻi lāʻau a me ka hoʻomohala ʻana.ʻO kāna ʻano hana i hoʻonohonoho pono ʻia e hiki ai ke hoʻololi a me ka hoʻololi ʻana, e lilo ia i mea koʻikoʻi i ka hana ʻana o Volorazan.
ʻO ka helu CAS 881674-56-2 he mea hōʻike kūʻokoʻa no kēia pūhui waena, e hōʻoiaʻiʻo ana i kona ʻike ʻia a me ka hōʻoia maikaʻi i nā noi lāʻau lapaʻau like ʻole.Mālama kēia i ka hilinaʻi a me ka kūlike o Vorolazan Intermediate 5 i ka noiʻi lāʻau lapaʻau, hoʻomohala a me ka hana ʻana.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.